M&A Deal Summary |
|
---|---|
Date | 2019-02-13 |
Target | Auris Health |
Sector | Medical Products |
Buyer(s) | Ethicon Endo-Surgery |
Deal Type | Add-on Acquisition |
Deal Value | 3.4B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Ethicon Endo-Surgery (EES) has an endless supply on hand. A subsidiary of Johnson & Johnson, the company makes surgical devices and equipment for open surgeries and minimally invasive procedures in the areas of bariatrics, gastrointestinal health, gynecology, and surgical oncology.
DEAL STATS | # |
---|---|
Overall | 8 of 8 |
Sector (Medical Products) | 7 of 7 |
Type (Add-on Acquisition) | 8 of 8 |
State (California) | 3 of 3 |
Country (United States) | 8 of 8 |
Year (2019) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-02-17 |
Torax Medical
Shoreview, Minnesota, United States Torax Medical, Inc. is a medical device company that manufactures and markets the LINX® Reflux Management System, a novel minimally invasive device for the surgical treatment of GERD. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-12-13 |
Acclarent
Menlo Park, California, United States Acclarent is a medical device company dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. It has developed the Balloon Sinuplasty system: a novel, endoscopic, catheter-based technology used by surgeons for sinusitis patients. Acclarent was formed in 2004 and is based in Menlo Park, California. |
Sell | $275M |